Approach to polyneuropathy: Clinical sciences
Introduction0:00–0:48
Polyneuropathy is a condition associated with demyelination or axonal injury of multiple peripheral nerves, which can result in numbness, weakness, and pain.
Now, hereditary polyneuropathies, which are caused by genetic mutations, include conditions like Friedreich ataxia, adrenomyeloneuropathy, and Charcot-Marie-Tooth disease.
On the flip side, acquired polyneuropathies, which can be caused by autoimmune disease, infections, chronic conditions, or nutritional deficiencies, include conditions like Guillain-Barré syndrome, diabetic neuropathy, chronic alcohol use, and vitamin B12 deficiency.
Now, if your patient presents with chief concerns suggestive of polyneuropathy, first, obtain a focused history and physical examination.
Focused H&P0:48–2:02
History will typically reveal progressive bilateral symptoms, such as numbness and tingling of the extremities. Sometimes, the patient might report muscle weakness and trouble with walking.
On the exam, assess the patient’s sensation, using different modalities, such as light touch, pinprick, and vibration. Also, be sure to check their muscle strength in extremities.
The exam will reveal bilateral symmetric loss of sensation, sometimes in combination with muscle weakness. Additionally, you will notice hyporeflexia or areflexia.
The physical exam might also reveal muscle atrophy and gait ataxia. Finally, be sure to perform Romberg testing.
First, ask the patient to stand with their feet together and arms at their sides, and instruct them to close their eyes.
By closing their eyes, you will remove visual cues that help maintain balance. If you notice any swaying or loss of balance, the test is positive, indicating impaired proprioception.
These findings are suggestive of polyneuropathy, so be sure to assess for the family history of neuropathy. If present, consider hereditary polyneuropathies, such as Friedreich ataxia, adrenomyeloneuropathy, and Charcot-Marie-Tooth disease.
Hereditary polyneuropathy2:02–2:22
First, let’s focus on Friedreich ataxia, which is an autosomal recessive condition that affects not just the peripheral nerves, but also the cerebellum and dorsal root ganglia, as well as dorsal columns, lateral corticospinal tracts, and spinocerebellar tracts.
Friedreich Ataxia 2:22–3:44
The patient will usually report symptom onset during childhood or adolescence. In addition to the previously mentioned symptoms of polyneuropathy, they will complain of frequent staggering or falling while walking.
They might also report slurred speech or difficulty swallowing, while their history might reveal chronic conditions like cardiomyopathy or diabetes.
Next, the exam will reveal loss of proprioceptive and vibratory sensation and a positive Romberg test. You will also notice limb ataxia, such as dysmetria on finger-to-nose testing, and truncal ataxia, like a wide-based unsteady gait.
Finally, in some individuals, you might notice scoliosis, pes cavus, and hammer toes. With these findings, consider Friedreich ataxia and obtain genetic testing.
If you identify a mutation in the frataxin gene and expanded GAA trinucleotide repeats, diagnose Friedreich ataxia. Now, let’s move on to adrenomyeloneuropathy, which is an X-linked condition characterized by impaired peroxisomal oxidation and accumulation of very long-chain fatty acids.
Adrenomyeloneuropathy3:44–5:42
Ultimately, this results in dysfunction of the adrenal glands, spinal cord, and peripheral nerves. In this case, symptoms typically start in early or middle adulthood.
Patients report stiffness, weakness, numbness, and tingling in the legs, causing difficulty walking. Also, they will report urinary dysfunction because of progressive spinal cord atrophy.
Some patients might develop white matter disease, causing cognitive decline, as well as vision and hearing loss. Because of adrenal insufficiency, they might also complain of fatigue, weight loss, and darkening of focal areas of the skin.
In addition to findings of peripheral neuropathy, the exam will reveal spasticity and weakness, particularly in the lower extremities.
There is loss of proprioception and vibration, and a positive Romberg. Finally, you may find skin hyperpigmentation, especially in areas of high sunlight exposure or friction, such as the hands, elbows, and knees.
With these findings, you should suspect adrenomyeloneuropathy, so proceed with genetic testing and be sure to check levels of very long-chain fatty acids.
If testing reveals mutations in the ABCD1 gene and elevated levels of very long-chain fatty acids, diagnose adrenomyeloneuropathy.
Here's a clinical pearl to keep in mind! Another form of the disease is adrenoleukodystrophy, with the main clinical manifestations related to the disease of the white matter, leukodystrophy, and the adrenal glands.
This phenotype usually presents in early childhood. Finally, let’s discuss Charcot-Marie-Tooth disease, which is the most common type of hereditary neuropathy.
Charcot-Marie-Tooth Type 1A 5:42–7:12
Charcot-Marie-Tooth disease consists of several different variants, the most common being Type 1A, which is inherited in an autosomal dominant pattern.
Your patient will typically present during childhood or adolescence and report leg or ankle weakness with difficulty walking.
In addition to bilateral loss of sensation, the exam will reveal the loss of deep tendon reflexes and muscle atrophy of the legs, causing an “inverted champagne bottle” appearance.
Additionally, you will notice unilateral or bilateral foot drop due to ankle dorsiflexion weakness, causing a steppage gait.
In other words, the patient will lift their leg higher than usual to avoid dragging their toes on the ground. You will also find foot deformities, like pes cavus and hammer toes.
With these findings, consider Charcot-Marie-Tooth disease, and proceed with genetic testing. If genetic testing shows duplication of the PMP22 gene on chromosome 17, diagnose Charcot-Marie-Tooth type 1A.
Here’s a high-yield fact! Charcot-Marie-Tooth Type 1 is associated with demyelination, while Charcot-Marie-Tooth Type 2 is characterized by axonal injury and tends to present later in life.
Alright, let’s switch gears and discuss individuals with no family history of neuropathy. In this case, consider acquired polyneuropathies, so your first step is to determine the timing of symptom progression.
Acquired polyneuropathies 7:12–7:37
If symptoms progress rapidly over days to weeks, think of Guillain-Barré syndrome and critical illness polyneuropathy. First, let’s take a look at Guillain-Barré syndrome, also known as acute inflammatory demyelinating polyradiculoneuropathy, which is associated with progressive weakness that starts in the legs and spreads upwards.
Guillain-Barré Syndrome 7:37–9:32
Additionally, history might reveal blurry or double vision, facial weakness, and difficulty swallowing or speaking. The patient might also report back pain.
Several important clues to keep in mind include recent vaccination as well as a recent respiratory or gastrointestinal infection.
Moreover, the most common gastrointestinal infection associated with this condition is Campylobacter pylori infection, which usually occurs when eating raw or undercooked meat.
On the exam, in addition to bilateral sensory loss and decreased or absent reflexes, you will notice bilateral symmetric limb weakness.
Other important findings might include cranial nerve dysfunction, such as facial palsy or ophthalmoparesis. In severe cases, you might notice respiratory muscle and truncal weakness.
In this case, consider Guillain-Barré syndrome, so your next step is to obtain a CSF sample for analysis. If the CSF analysis shows albuminocytologic dissociation, meaning an elevated protein level with a normal white blood cell count, diagnose Guillain-Barré syndrome.
Now, here’s a clinical pearl to keep in mind! Symptoms of Guillain-Barré syndrome tend to plateau in 4 weeks.
If symptoms continue to progress longer than that, or the patient has relapses, consider chronic inflammatory demyelinating polyradiculoneuropathy.
Now, let’s discuss critical illness polyneuropathy, which is most commonly seen in individuals requiring intensive care, typically for conditions such as sepsis, multisystem organ failure, and respiratory failure.
Critical Illness Polyneuropathy 9:32–10:26
On the exam, you will notice respiratory, truncal, and limb muscle weakness. Remember that in these patients, motor deficits are usually more severe than sensory deficits.
Also, there will be no involvement of cranial nerves. Based on these findings, diagnose critical illness polyneuropathy.
Now, here’s a clinical pearl! Individuals requiring ICU management can also develop critical illness myopathy, which is characterized by muscle injury and subsequent muscle atrophy and weakness.
In this case, the physical exam will reveal no sensory deficits. Now, let’s review common causes of acquired polyneuropathies that progress over months to years.
Diabetic Neuropathy 10:26–11:30
In this case, you should think of diabetic neuropathy, alcoholic neuropathy, and vitamin B12 deficiency. First, let’s focus on diabetic neuropathy, which is characterized by slowly progressive numbness and tingling that starts in the feet and gradually spreads upwards towards the thighs.
Once the numbness and tingling reach the thighs, the hands might become involved as well. The patient might also report burning pain and weakness in the extremities.
History will also reveal that the patient has diabetes mellitus. On exam, sensory loss is more prominent distally in the limbs and affects the legs more than the arms.
This is known as a stocking-glove pattern. In severe cases, you might find limb weakness.
With these findings, diagnose diabetic neuropathy, which is the most common cause of acquired polyneuropathies. Next, let’s discuss alcoholic neuropathy.
These individuals will report slowly progressive numbness and tingling that started in the feet and ascended upwards. They might also complain of burning pain or weakness.
Alcoholic Neuropathy 11:30–12:07
Instead of diabetes, history reveals chronic alcohol use and possibly poor nutrition. On exam, you will find greater distal than proximal sensory loss that affects the legs more than the arms.
Again, you might notice limb weakness. These findings are suggestive of alcoholic neuropathy.
Finally, let’s focus on vitamin B12 deficiency, which is characterized by polyneuropathy and combined degeneration of the lateral corticospinal tracts and dorsal columns.
Vitamin B12 Deficiency12:07–13:55
History might reveal risk factors for poor B12 absorption, such as pernicious anemia, use of antacids or proton pump inhibitors, gastritis, and gastrointestinal interventions, such as gastrectomy or ileocecal resection.
Another important risk factor is a vegetarian- or vegan diet. Next up are physical exam findings.
Atrophy of the dorsal columns will result in loss of vibration and proprioception in the limbs, while the involvement of the lateral corticospinal tracts and peripheral nerves can cause both hyper- and hyporeflexia.
Finally, the exam will reveal limb weakness, a positive Romberg test, and an ataxic gait. With these findings, consider vitamin B12 deficiency.
Your next step is to check vitamin B12 levels. If the levels are low, diagnose vitamin B12 deficiency.
Now, here's a high-yield fact! In early or mild B12 deficiency, the B12 level might be normal.
In this case, you should check methylmalonic acid and homocysteine levels. If labs reveal high values, diagnose B12 deficiency.
Alright, as a quick recap… If a patient presents with chief concerns suggestive of polyneuropathy, your first step is to assess for a family history of neuropathy.
Review13:55–14:41
If present, consider hereditary polyneuropathies such as Friedreich ataxia, adrenomyeloneuropathy, and Charcot-Marie-Tooth disease.
If family history is absent, consider acquired polyneuropathies, so be sure to determine the timing of symptom progression.
If symptom progression is rapid, over days to weeks, consider Guillain-Barré syndrome and critical illness polyneuropathy.
On the flip side, if symptom progression is slow, over months to years, consider polyneuropathy secondary to diabetes, alcohol use disorder, and vitamin B12 deficiency.
- "Diagnosis and management of Guillain-Barré syndrome in ten steps. " Nat Rev Neurol. (2019;15(11):671-683. )
- "Chapter 446: Peripheral neuropathy. In: Loscalzo J, Fauci A, Kasper D, Hauser S, Longo D, Jameson J, eds. Harrison’s Principles of Internal Medicine. 21st ed. " McGraw-Hill Education; (2022.)
- "Diabetic neuropathies. " Continuum (Minneap Minn). (2023;29(5):1401-1417. )
- "Hereditary neuropathies. " Continuum (Minneap Minn) (2023;29(5):1514-1537. )
- "Alcohol-related peripheral neuropathy: a systematic review and meta-analysis. " J Neurol. (2019;266(12):2907-2919. )
- "Nutritional neuropathies. " Continuum (Minneap Minn) (2023;29(5):1469-1491. )
- "Chapter 36: Inherited metabolic diseases of the nervous system. In: Ropper AH, Samuels MA, Klein JP, Prasad S, eds. Adams and Victor's Principles of Neurology. 12th ed. " McGraw-Hill Education (2023. )
- "Chapter 43: Diseases of the peripheral nerves. In: Ropper AH, Samuels MA, Klein JP, Prasad S, eds. Adams and Victor's Principles of Neurology. 12th ed. " McGraw-Hill Education (2023. )
No notes for this video yet
Try adding a note below